speb/financial-data huggingface dataset:
DEA cash_flow (annual, 2023-12-31) — Purchase Of Business: -17736000.00
DEA cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -109375000.00
DEA balance_sheet (annual, 2023-12-31) — Receivables: 66274000.00
DEA income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 105155000.00
DEA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 88562000.00
DEA cash_flow (annual, 2023-12-31) — Repayment Of Debt: -204752000.00
DEA balance_sheet (annual, 2023-12-31) — Restricted Cash: 12558000.00
DEA income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 1661000.00
DEA balance_sheet (annual, 2023-12-31) — Retained Earnings: 112301000.00
DEA cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 0.00
DEA income_statement (annual, 2023-12-31) — Selling General And Administration: 27118000.00
DEA balance_sheet (annual, 2023-12-31) — Share Issued: 40389298.00
DEA income_statement (annual, 2023-12-31) — Special Income Charges: -1661000.00
DEA cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5747000.00
DEA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1322201000.00
DEA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1173748000.00
DEA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -348810.00
DEA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
DEA balance_sheet (annual, 2023-12-31) — Total Assets: 2879752000.00
DEA balance_sheet (annual, 2023-12-31) — Total Capitalization: 2538036000.00
DEA balance_sheet (annual, 2023-12-31) — Total Debt: 1294835000.00
DEA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1409516000.00
DEA income_statement (annual, 2023-12-31) — Total Expenses: 220835000.00
DEA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1470236000.00
DEA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2791539000.00
DEA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1228315000.00
DEA income_statement (annual, 2023-12-31) — Total Unusual Items: -1661000.00
DEA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1661000.00
DEA balance_sheet (annual, 2023-12-31) — Working Capital: -153708000.00
DEA balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 113766000.00
DEA balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 2002000.00
DEA balance_sheet (quarterly, 2024-09-30) — Current Debt: 100000000.00
DEA balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 100000000.00
DEA balance_sheet (quarterly, 2024-09-30) — Line Of Credit: 100000000.00
DEA balance_sheet (quarterly, 2024-09-30) — Payables: 113766000.00
DEA income_statement (annual, 2024-12-31) — +Operating Expense: 122310000.00
DEA income_statement (annual, 2024-12-31) — +Total Revenue: 302052000.00
DEA balance_sheet (annual, 2024-12-31) — Accounts Payable: 101271000.00
DEA balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 101271000.00
DEA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 71172000.00
DEA balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1874193000.00
DEA cash_flow (annual, 2024-12-31) — Amortization Cash Flow: -1935000.00
DEA cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: -1935000.00
DEA cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
DEA income_statement (annual, 2024-12-31) — Basic Average Shares: 41377580.00
DEA income_statement (annual, 2024-12-31) — Basic EPS: 0.45
DEA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 21939000.00
DEA balance_sheet (annual, 2024-12-31) — Capital Stock: 432000.00
DEA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 19353000.00
DEA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 19353000.00
DEA cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -115909000.00
DEA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 252875000.00
DEA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -409645000.00
DEA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 162635000.00
DEA cash_flow (annual, 2024-12-31) — Change In Account Payable: 4875000.00
DEA cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 45152000.00
DEA cash_flow (annual, 2024-12-31) — Change In Payable: 4875000.00
DEA cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 4875000.00
DEA cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -2975000.00
DEA cash_flow (annual, 2024-12-31) — Change In Receivables: -2901000.00
DEA cash_flow (annual, 2024-12-31) — Change In Working Capital: 44151000.00
DEA cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1672000.00
DEA cash_flow (annual, 2024-12-31) — Changes In Cash: 5865000.00
DEA balance_sheet (annual, 2024-12-31) — Common Stock: 432000.00
DEA cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -115909000.00
DEA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1321118000.00
DEA cash_flow (annual, 2024-12-31) — Common Stock Issuance: 71809000.00
DEA income_statement (annual, 2024-12-31) — Cost Of Revenue: 101075000.00
DEA balance_sheet (annual, 2024-12-31) — Current Assets: 133057000.00
DEA balance_sheet (annual, 2024-12-31) — Current Debt: 274550000.00
DEA balance_sheet (quarterly, 2024-12-31) — Current Debt: 274550000.00
DEA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 274550000.00
DEA balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 274550000.00
DEA balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 120977000.00
DEA balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 120977000.00
DEA balance_sheet (annual, 2024-12-31) — Current Liabilities: 496798000.00
DEA cash_flow (annual, 2024-12-31) — Depreciation: 96333000.00
DEA cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 94398000.00
DEA income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 96333000.00
DEA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 94398000.00
DEA income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 96333000.00
DEA balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
DEA income_statement (annual, 2024-12-31) — Diluted Average Shares: 41503418.00
DEA income_statement (annual, 2024-12-31) — Diluted EPS: 0.45
DEA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 18999000.00
DEA cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 12109000.00
DEA cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 2037000.00
DEA cash_flow (quarterly, 2024-12-31) — Dividends Received Cfi: 0.00
DEA income_statement (annual, 2024-12-31) — EBIT: 83011000.00
DEA income_statement (annual, 2024-12-31) — EBITDA: 179344000.00
DEA income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 6051000.00
DEA cash_flow (annual, 2024-12-31) — End Cash Position: 27804000.00
DEA balance_sheet (annual, 2024-12-31) — Financial Assets: 717000.00
DEA balance_sheet (quarterly, 2024-12-31) — Financial Assets: 717000.00
DEA cash_flow (annual, 2024-12-31) — Financing Cash Flow: 252875000.00
DEA cash_flow (annual, 2024-12-31) — Free Cash Flow: 162635000.00
DEA cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -171000.00
DEA income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 171000.00
DEA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -685361000.00
DEA income_statement (annual, 2024-12-31) — General And Administrative Expense: 24450000.00
DEA balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 161425000.00
DEA income_statement (annual, 2024-12-31) — Gross Profit: 200977000.00
DEA income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
DEA income_statement (annual, 2024-12-31) — Interest Expense: 62433000.00
DEA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 62433000.00
DEA cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 61949000.00
DEA balance_sheet (annual, 2024-12-31) — Invested Capital: 2919939000.00
DEA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -409645000.00
DEA balance_sheet (annual, 2024-12-31) — Investment Properties: 2572095000.00
DEA balance_sheet (annual, 2024-12-31) — Investments And Advances: 316521000.00
DEA balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 316521000.00
DEA cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 71809000.00
DEA cash_flow (annual, 2024-12-31) — Issuance Of Debt: 817550000.00
DEA balance_sheet (annual, 2024-12-31) — Line Of Credit: 274550000.00
DEA balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 274550000.00
DEA balance_sheet (annual, 2024-12-31) — Loans Receivable: 34081000.00
DEA balance_sheet (annual, 2024-12-31) — Long Term Debt: 1324271000.00
DEA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1324271000.00
DEA cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 817550000.00
DEA cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -511798000.00
DEA balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 316521000.00
DEA balance_sheet (annual, 2024-12-31) — Minority Interest: 65999000.00
DEA income_statement (annual, 2024-12-31) — Minority Interests: -1025000.00
DEA cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -40071000.00
DEA cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
DEA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 71809000.00
DEA balance_sheet (annual, 2024-12-31) — Net Debt: 1579468000.00
DEA income_statement (annual, 2024-12-31) — Net Income: 19553000.00
DEA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 18999000.00
DEA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 20578000.00
DEA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 19553000.00
DEA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 19553000.00
DEA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 20578000.00
DEA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 20578000.00
DEA income_statement (annual, 2024-12-31) — Net Interest Income: -62433000.00
DEA cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -337382000.00
DEA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 305752000.00
DEA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 305752000.00
DEA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -62433000.00
DEA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -8777000.00
DEA cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -34229000.00
DEA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1159693000.00
DEA income_statement (annual, 2024-12-31) — Normalized EBITDA: 181051000.00
DEA income_statement (annual, 2024-12-31) — Normalized Income: 20901530.00
DEA cash_flow (annual, 2024-12-31) — Operating Cash Flow: 162635000.00
DEA cash_flow (annual, 2024-12-31) — Operating Gains Losses: -171000.00
DEA income_statement (annual, 2024-12-31) — Operating Income: 78667000.00
DEA income_statement (annual, 2024-12-31) — Operating Revenue: 291903000.00
DEA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 43188223.00
DEA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -685361000.00
DEA income_statement (annual, 2024-12-31) — Other Gand A: 24450000.00
DEA income_statement (annual, 2024-12-31) — Other Income Expense: 4344000.00
DEA balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 161425000.00
DEA cash_flow (annual, 2024-12-31) — Other Non Cash Items: -13165000.00
DEA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 39256000.00
DEA balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 14885000.00
DEA income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 554000.00
DEA balance_sheet (annual, 2024-12-31) — Payables: 101271000.00
DEA balance_sheet (quarterly, 2024-12-31) — Payables: 101271000.00
DEA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 101271000.00
DEA income_statement (annual, 2024-12-31) — Pretax Income: 20578000.00
DEA income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 1527000.00
DEA cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 1527000.00
DEA cash_flow (annual, 2024-12-31) — Purchase Of Business: -40071000.00
DEA cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
DEA cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -339555000.00
DEA balance_sheet (annual, 2024-12-31) — Receivables: 105253000.00
DEA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 103010000.00
DEA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 94398000.00
DEA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -511798000.00
DEA balance_sheet (annual, 2024-12-31) — Restricted Cash: 8451000.00
DEA income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 1878000.00
DEA balance_sheet (annual, 2024-12-31) — Retained Earnings: 131854000.00
DEA cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 2173000.00
DEA income_statement (annual, 2024-12-31) — Selling General And Administration: 24450000.00
DEA balance_sheet (annual, 2024-12-31) — Share Issued: 43188223.00
DEA income_statement (annual, 2024-12-31) — Special Income Charges: -1878000.00
DEA cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3208000.00
DEA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1321118000.00
DEA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1159693000.00
DEA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -358470.00
DEA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
DEA balance_sheet (annual, 2024-12-31) — Total Assets: 3223071000.00
DEA balance_sheet (annual, 2024-12-31) — Total Capitalization: 2645389000.00
DEA balance_sheet (annual, 2024-12-31) — Total Debt: 1598821000.00
DEA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1387117000.00
DEA income_statement (annual, 2024-12-31) — Total Expenses: 223385000.00
DEA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1835954000.00
DEA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3090014000.00
DEA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1339156000.00
DEA income_statement (annual, 2024-12-31) — Total Unusual Items: -1707000.00
DEA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1707000.00
DEA balance_sheet (annual, 2024-12-31) — Working Capital: -363741000.00
DEA income_statement (quarterly, 2025-03-31) — +Operating Expense: 32774000.00
DEA income_statement (quarterly, 2025-03-31) — +Total Revenue: 78675000.00
DEA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 91161000.00
DEA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 70531000.00
DEA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1915891000.00
DEA cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: -518000.00
DEA cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: -518000.00
DEA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 43224145.00
DEA income_statement (quarterly, 2025-03-31) — Basic EPS: 0.07
DEA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 27804000.00
DEA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 447000.00
DEA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 8459000.00
DEA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 8459000.00
DEA cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -30240000.00
DEA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 10737000.00
DEA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -45239000.00
DEA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 24187000.00
DEA cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -3399000.00
DEA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -875000.00
DEA cash_flow (quarterly, 2025-03-31) — Change In Payable: -3399000.00
DEA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3399000.00
DEA cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -3312000.00
DEA cash_flow (quarterly, 2025-03-31) — Change In Receivables: -314000.00
DEA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -7900000.00
DEA cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 617000.00
DEA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -10315000.00
DEA balance_sheet (quarterly, 2025-03-31) — Common Stock: 447000.00
DEA cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -30240000.00
DEA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1333691000.00
DEA cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 41270000.00
DEA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 25756000.00
DEA balance_sheet (quarterly, 2025-03-31) — Current Assets: 131780000.00
DEA balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 118340000.00
DEA balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 118340000.00
DEA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 209501000.00
DEA cash_flow (quarterly, 2025-03-31) — Depreciation: 26797000.00
DEA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 26279000.00
DEA income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 26797000.00
DEA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 26279000.00
DEA income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 26797000.00
DEA balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 1323000.00
DEA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 43372207.00
DEA income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.07
DEA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2920000.00
DEA cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 3795000.00
DEA income_statement (quarterly, 2025-03-31) — EBIT: 21660000.00
DEA income_statement (quarterly, 2025-03-31) — EBITDA: 48457000.00
DEA income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 1822000.00
DEA cash_flow (quarterly, 2025-03-31) — End Cash Position: 17489000.00
DEA balance_sheet (quarterly, 2025-03-31) — Financial Assets: 145000.00
DEA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 10737000.00
DEA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 24187000.00
DEA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -717628000.00
DEA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 6215000.00
DEA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 155663000.00
DEA income_statement (quarterly, 2025-03-31) — Gross Profit: 52919000.00
DEA income_statement (quarterly, 2025-03-31) — Interest Expense: 18377000.00
DEA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 18377000.00
DEA cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 15640000.00
DEA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2934823000.00
DEA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -45239000.00
DEA balance_sheet (quarterly, 2025-03-31) — Investment Properties: 2573509000.00
DEA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 314546000.00
DEA balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 314546000.00
DEA cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 41270000.00
DEA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 180500000.00
DEA balance_sheet (quarterly, 2025-03-31) — Loans Receivable: 43760000.00
DEA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1601132000.00
DEA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1601132000.00
DEA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 180500000.00
DEA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -176127000.00
DEA balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 314546000.00
DEA balance_sheet (quarterly, 2025-03-31) — Minority Interest: 64867000.00
DEA income_statement (quarterly, 2025-03-31) — Minority Interests: -156000.00
DEA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 41270000.00
DEA balance_sheet (quarterly, 2025-03-31) — Net Debt: 1592673000.00
DEA income_statement (quarterly, 2025-03-31) — Net Income: 3127000.00
DEA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2920000.00
DEA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3283000.00
DEA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3127000.00
DEA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3127000.00
DEA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 3283000.00
DEA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 3283000.00
DEA income_statement (quarterly, 2025-03-31) — Net Interest Income: -18377000.00
DEA cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: -36698000.00
DEA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 4373000.00
DEA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 4373000.00
DEA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -18377000.00
DEA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -4666000.00
DEA cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -8541000.00
DEA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1178028000.00
DEA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 48764000.00
DEA income_statement (quarterly, 2025-03-31) — Normalized Income: 3369530.00
DEA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 24187000.00
DEA income_statement (quarterly, 2025-03-31) — Operating Income: 20145000.00
DEA income_statement (quarterly, 2025-03-31) — Operating Revenue: 76168000.00
DEA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 44702490.00
DEA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -717628000.00
DEA income_statement (quarterly, 2025-03-31) — Other Gand A: 6215000.00
DEA income_statement (quarterly, 2025-03-31) — Other Income Expense: 1515000.00
DEA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 155663000.00
DEA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -2453000.00
DEA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 48964000.00
DEA balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 14093000.00
DEA income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 207000.00
DEA balance_sheet (quarterly, 2025-03-31) — Payables: 91161000.00
DEA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 91161000.00
DEA income_statement (quarterly, 2025-03-31) — Pretax Income: 3283000.00
DEA income_statement (quarterly, 2025-03-31) — Provision For Doubtful Accounts: -238000.00
DEA cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -238000.00
DEA cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: -36698000.00
DEA balance_sheet (quarterly, 2025-03-31) — Receivables: 114291000.00
DEA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 26274000.00
DEA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 26279000.00
DEA income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 17799000.00
DEA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -176127000.00
DEA balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 9030000.00
DEA income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 307000.00
DEA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 134981000.00
DEA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 6215000.00
DEA balance_sheet (quarterly, 2025-03-31) — Share Issued: 44702490.00
DEA income_statement (quarterly, 2025-03-31) — Special Income Charges: -307000.00
DEA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1421000.00
DEA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1333691000.00
DEA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1178028000.00
DEA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -64470.00
DEA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
DEA balance_sheet (quarterly, 2025-03-31) — Total Assets: 3224607000.00
DEA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2934823000.00
DEA balance_sheet (quarterly, 2025-03-31) — Total Debt: 1601132000.00
DEA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1398558000.00
DEA income_statement (quarterly, 2025-03-31) — Total Expenses: 58530000.00
DEA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1826049000.00
DEA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3092827000.00
DEA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1616548000.00
DEA income_statement (quarterly, 2025-03-31) — Total Unusual Items: -307000.00
DEA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -307000.00
DEA balance_sheet (quarterly, 2025-03-31) — Working Capital: -77721000.00
DEA income_statement (quarterly, 2025-06-30) — +Operating Expense: 34802000.00
DEA income_statement (quarterly, 2025-06-30) — +Total Revenue: 84234000.00
DEA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 115110000.00
DEA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 75506000.00
DEA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1934279000.00
DEA cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: -488000.00
DEA cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: -488000.00
DEA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 45011585.00
DEA income_statement (quarterly, 2025-06-30) — Basic EPS: 0.09
DEA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 17489000.00
DEA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 453000.00
DEA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 4697000.00
DEA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 4697000.00
DEA cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -21312000.00
DEA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 105139000.00
DEA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -146688000.00
DEA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 38111000.00
DEA cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 3474000.00
DEA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 2182000.00
DEA cash_flow (quarterly, 2025-06-30) — Change In Payable: 3474000.00
DEA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 3474000.00
DEA cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1277000.00
DEA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -5102000.00
DEA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1831000.00
DEA cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -4376000.00
DEA cash_flow (quarterly, 2025-06-30) — Changes In Cash: -3438000.00
DEA balance_sheet (quarterly, 2025-06-30) — Common Stock: 453000.00
DEA cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -21312000.00
DEA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1334329000.00
DEA cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 5368000.00
DEA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 27696000.00
DEA balance_sheet (quarterly, 2025-06-30) — Current Assets: 121499000.00
DEA balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 118659000.00
DEA balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 118659000.00
DEA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 233769000.00
DEA cash_flow (quarterly, 2025-06-30) — Depreciation: 28534000.00
DEA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 28046000.00
DEA income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 28534000.00
DEA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 28046000.00
DEA income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 28534000.00
DEA balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 2903000.00
DEA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 45111753.00
DEA income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.09
DEA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 3931000.00
DEA cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 5874000.00
DEA income_statement (quarterly, 2025-06-30) — EBIT: 23214000.00
DEA income_statement (quarterly, 2025-06-30) — EBITDA: 51748000.00
DEA income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 1840000.00
DEA cash_flow (quarterly, 2025-06-30) — End Cash Position: 14051000.00
DEA balance_sheet (quarterly, 2025-06-30) — Financial Assets: 0.00
DEA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 105139000.00
DEA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 38111000.00
DEA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -739455000.00
DEA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 6807000.00
DEA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 188006000.00
DEA income_statement (quarterly, 2025-06-30) — Gross Profit: 56538000.00
DEA income_statement (quarterly, 2025-06-30) — Interest Expense: 18960000.00
DEA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 18960000.00
DEA cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 18142000.00
DEA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3057221000.00
DEA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -146688000.00
DEA balance_sheet (quarterly, 2025-06-30) — Investment Properties: 2682915000.00
DEA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 310514000.00
DEA balance_sheet (quarterly, 2025-06-30) — Investmentsin Joint Venturesat Cost: 310514000.00
DEA cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 5368000.00
DEA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 160500000.00
DEA balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 31942000.00
DEA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1722892000.00
DEA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1722892000.00
DEA cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 160500000.00
DEA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -39138000.00
DEA balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 310514000.00
DEA balance_sheet (quarterly, 2025-06-30) — Minority Interest: 52203000.00
DEA income_statement (quarterly, 2025-06-30) — Minority Interests: -183000.00
DEA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 5368000.00
DEA balance_sheet (quarterly, 2025-06-30) — Net Debt: 1718195000.00
DEA income_statement (quarterly, 2025-06-30) — Net Income: 4071000.00
DEA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 3931000.00
DEA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 4254000.00
DEA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 4071000.00
DEA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 4071000.00
DEA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 4254000.00
DEA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 4254000.00
DEA income_statement (quarterly, 2025-06-30) — Net Interest Income: -18960000.00
DEA cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -159868000.00
DEA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 121362000.00
DEA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 121362000.00
DEA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -18960000.00
DEA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -279000.00
DEA cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 13180000.00
DEA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1146323000.00
DEA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 52110000.00
DEA income_statement (quarterly, 2025-06-30) — Normalized Income: 4356980.00
DEA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 38111000.00
DEA income_statement (quarterly, 2025-06-30) — Operating Income: 21736000.00
DEA income_statement (quarterly, 2025-06-30) — Operating Revenue: 80989000.00
DEA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 45354115.00
DEA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -739455000.00
DEA income_statement (quarterly, 2025-06-30) — Other Gand A: 6807000.00
DEA income_statement (quarterly, 2025-06-30) — Other Income Expense: 1478000.00
DEA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 188006000.00
DEA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -2750000.00
DEA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 56493000.00
DEA balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 13331000.00
DEA income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 140000.00
DEA balance_sheet (quarterly, 2025-06-30) — Payables: 115110000.00
DEA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 115110000.00
DEA income_statement (quarterly, 2025-06-30) — Pretax Income: 4254000.00
DEA income_statement (quarterly, 2025-06-30) — Provision For Doubtful Accounts: -539000.00
DEA cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -539000.00
DEA cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -159868000.00
DEA balance_sheet (quarterly, 2025-06-30) — Receivables: 107448000.00
DEA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 28184000.00
DEA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 28046000.00
DEA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -39138000.00
DEA balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 9354000.00
DEA income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 362000.00
DEA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 139052000.00
DEA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6807000.00
DEA balance_sheet (quarterly, 2025-06-30) — Share Issued: 45354115.00
DEA income_statement (quarterly, 2025-06-30) — Special Income Charges: -362000.00
DEA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1395000.00
DEA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1334329000.00
DEA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1146323000.00
DEA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -76020.00
DEA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
DEA balance_sheet (quarterly, 2025-06-30) — Total Assets: 3359427000.00
DEA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3057221000.00
DEA balance_sheet (quarterly, 2025-06-30) — Total Debt: 1722892000.00
DEA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1386532000.00
DEA income_statement (quarterly, 2025-06-30) — Total Expenses: 62498000.00
DEA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1972895000.00
DEA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 3237928000.00
DEA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1739126000.00
DEA income_statement (quarterly, 2025-06-30) — Total Unusual Items: -362000.00
DEA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -362000.00
DEA balance_sheet (quarterly, 2025-06-30) — Working Capital: -112270000.00
DEA income_statement (quarterly, 2025-09-30) — +Operating Expense: 35056000.00
DEA income_statement (quarterly, 2025-09-30) — +Total Revenue: 86151000.00
DEA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 65784000.00
DEA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1952689000.00
DEA cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: -421000.00
DEA cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: -421000.00
DEA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 45337184.00
DEA income_statement (quarterly, 2025-09-30) — Basic EPS: 0.02
DEA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 14051000.00
DEA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 461000.00
DEA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 4355000.00
DEA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 4355000.00
DEA cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -21330000.00
DEA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -89175000.00
DEA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -65632000.00
DEA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 154965000.00
DEA cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 9797000.00
DEA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 103762000.00
DEA cash_flow (quarterly, 2025-09-30) — Change In Payable: 9797000.00
DEA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 9797000.00
DEA cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -6193000.00
DEA cash_flow (quarterly, 2025-09-30) — Change In Receivables: 10181000.00
DEA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 117547000.00
DEA cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 10449000.00
DEA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 158000.00
DEA balance_sheet (quarterly, 2025-09-30) — Common Stock: 461000.00
DEA cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -21330000.00
DEA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1333501000.00
DEA cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 16982000.00
DEA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 29529000.00
DEA balance_sheet (quarterly, 2025-09-30) — Current Assets: 114785000.00
DEA balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 220529000.00
DEA balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 220529000.00
DEA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 342097000.00
DEA cash_flow (quarterly, 2025-09-30) — Depreciation: 28946000.00
DEA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 28525000.00
DEA income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 28946000.00
DEA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 28525000.00
DEA income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 28946000.00
DEA balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 3046000.00
DEA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 45485375.00
DEA income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.02
DEA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1065000.00
DEA cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 5544000.00
DEA income_statement (quarterly, 2025-09-30) — EBIT: 20284000.00
DEA income_statement (quarterly, 2025-09-30) — EBITDA: 49230000.00
DEA income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 1556000.00
DEA cash_flow (quarterly, 2025-09-30) — End Cash Position: 14209000.00
DEA balance_sheet (quarterly, 2025-09-30) — Financial Assets: 0.00
DEA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -89175000.00
DEA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 154965000.00
DEA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -759914000.00
DEA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5808000.00
DEA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 190652000.00
DEA income_statement (quarterly, 2025-09-30) — Gross Profit: 56622000.00
DEA income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 2545000.00
DEA income_statement (quarterly, 2025-09-30) — Interest Expense: 19037000.00
DEA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 19037000.00
DEA cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 17890000.00
DEA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2972328000.00
DEA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -65632000.00
DEA balance_sheet (quarterly, 2025-09-30) — Investment Properties: 2709517000.00
DEA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 306526000.00
DEA balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 306526000.00
DEA cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 16982000.00
DEA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 83850000.00
DEA balance_sheet (quarterly, 2025-09-30) — Loans Receivable: 34792000.00
DEA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1638827000.00
DEA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1638827000.00
DEA cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 83850000.00
DEA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -166156000.00
DEA balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 306526000.00
DEA balance_sheet (quarterly, 2025-09-30) — Minority Interest: 51322000.00
DEA income_statement (quarterly, 2025-09-30) — Minority Interests: -34000.00
DEA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 16982000.00
DEA balance_sheet (quarterly, 2025-09-30) — Net Debt: 1634472000.00
DEA income_statement (quarterly, 2025-09-30) — Net Income: 1213000.00
DEA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1065000.00
DEA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1247000.00
DEA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1213000.00
DEA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1213000.00
DEA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1247000.00
DEA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1247000.00
DEA income_statement (quarterly, 2025-09-30) — Net Interest Income: -19037000.00
DEA cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: -62446000.00
DEA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -82306000.00
DEA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -82306000.00
DEA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -19037000.00
DEA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2521000.00
DEA cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -3186000.00
DEA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1142849000.00
DEA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 52068000.00
DEA income_statement (quarterly, 2025-09-30) — Normalized Income: 3455020.00
DEA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 154965000.00
DEA income_statement (quarterly, 2025-09-30) — Operating Income: 21566000.00
DEA income_statement (quarterly, 2025-09-30) — Operating Revenue: 82833000.00
DEA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 46108379.00
DEA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -759914000.00
DEA income_statement (quarterly, 2025-09-30) — Other Gand A: 5808000.00
DEA income_statement (quarterly, 2025-09-30) — Other Income Expense: -1282000.00
DEA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 190652000.00
DEA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -2378000.00
DEA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 59949000.00
DEA balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 12636000.00
DEA income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 148000.00
DEA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 121568000.00
DEA income_statement (quarterly, 2025-09-30) — Pretax Income: 1247000.00
DEA income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: 302000.00
DEA cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 302000.00
DEA cash_flow (quarterly, 2025-09-30) — Purchase Of Investment Properties: -65938000.00
DEA balance_sheet (quarterly, 2025-09-30) — Receivables: 100576000.00
DEA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 29950000.00
DEA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 28525000.00
DEA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -166156000.00
DEA balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 9854000.00
DEA income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 293000.00
DEA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 140265000.00
DEA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5808000.00
DEA balance_sheet (quarterly, 2025-09-30) — Share Issued: 46108379.00
DEA income_statement (quarterly, 2025-09-30) — Special Income Charges: -2838000.00
DEA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1633000.00
DEA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1333501000.00
DEA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1142849000.00
DEA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -595980.00
DEA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
DEA balance_sheet (quarterly, 2025-09-30) — Total Assets: 3381429000.00
DEA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2972328000.00
DEA balance_sheet (quarterly, 2025-09-30) — Total Debt: 1638827000.00
DEA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1384823000.00
DEA income_statement (quarterly, 2025-09-30) — Total Expenses: 64585000.00
DEA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1996606000.00
DEA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3266644000.00
DEA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1654509000.00
DEA income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2838000.00
DEA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2838000.00
DEA balance_sheet (quarterly, 2025-09-30) — Working Capital: -227312000.00